Selinexor for CLL - mechanism of action and combination with ibrutinib
Jennifer Woyach, MD of The Ohio State University Comprehensive Cancer Center, Columbus, OH talks about selinexor for chronic lymphocytic leukaemia (CLL) at the 2016 International Workshop of the Germa...
Author: VJHemOnc
Added: 11/03/2016
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer | Cancer & Oncology | Chronic Leukemia | Chronic Lymphocytic Leukemia | Leukemia | Workshops